Could a sweetener beat a gut infection? new trial explores xylitol for c. diff in IBD
NCT ID NCT05852587
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if xylitol, a common sweetener, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 99 adults with mild or inactive IBD will take either a low or high dose of xylitol or a placebo for four weeks. Researchers will check stool samples over a year to see if the infection is gone and if symptoms improve.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIOIDES DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Amniotic cell secretions may fight gut inflammation and scarring — a lab study puts them to the test
- Could a diet change calm IBD by reshaping gut bacteria?
- Can a peer coach help young people take control of their chronic illness?
- Scientists hunt for hidden clues to inflammatory bowel disease
- Could skipping random biopsies during colonoscopy be just as safe for IBD patients?
- Can IBD patients safely stretch their infusion schedule? new study tests two strategies